- Home
- DCGO vs ABSI Comparison
DCGO vs ABSI Comparison
Compare DCGO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCGO
- ABSI
- Stock Information
- Founded
- DCGO 2015
- ABSI 2011
- Country
- DCGO United States
- ABSI United States
- Employees
- DCGO N/A
- ABSI N/A
- Industry
- DCGO Managed Health Care
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- DCGO Health Care
- ABSI Health Care
- Exchange
- DCGO Nasdaq
- ABSI Nasdaq
- Market Cap
- DCGO 417.4M
- ABSI 457.6M
- IPO Year
- DCGO N/A
- ABSI 2021
- Fundamental
- Price
- DCGO $4.12
- ABSI $2.55
- Analyst Decision
- DCGO Strong Buy
- ABSI Strong Buy
- Analyst Count
- DCGO 5
- ABSI 6
- Target Price
- DCGO $6.10
- ABSI $8.67
- AVG Volume (30 Days)
- DCGO 730.0K
- ABSI 1.5M
- Earning Date
- DCGO 11-07-2024
- ABSI 11-12-2024
- Dividend Yield
- DCGO N/A
- ABSI N/A
- EPS Growth
- DCGO 300.38
- ABSI N/A
- EPS
- DCGO 0.29
- ABSI N/A
- Revenue
- DCGO $694,968,328.00
- ABSI $4,207,000.00
- Revenue This Year
- DCGO $1.17
- ABSI $9.36
- Revenue Next Year
- DCGO N/A
- ABSI $198.59
- P/E Ratio
- DCGO $14.44
- ABSI N/A
- Revenue Growth
- DCGO 30.19
- ABSI N/A
- 52 Week Low
- DCGO $2.75
- ABSI $1.35
- 52 Week High
- DCGO $6.21
- ABSI $6.72
- Technical
- Relative Strength Index (RSI)
- DCGO 65.99
- ABSI 24.46
- Support Level
- DCGO $3.84
- ABSI $2.45
- Resistance Level
- DCGO $4.43
- ABSI $4.47
- Average True Range (ATR)
- DCGO 0.26
- ABSI 0.28
- MACD
- DCGO 0.02
- ABSI -0.15
- Stochastic Oscillator
- DCGO 71.63
- ABSI 4.96
About DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company has three reportable segments: Mobile Health Services, Transportation Services, and Corporate. Mobile Health Services is the key revenue-generating segment for the company.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.